140 related articles for article (PubMed ID: 10386485)
1. Zafirlukast in clinical practice: results of the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT) in patients with asthma.
Kemp JP; Korenblat PE; Scherger JE; Minkwitz M
J Fam Pract; 1999 Jun; 48(6):425-32. PubMed ID: 10386485
[TBL] [Abstract][Full Text] [Related]
2. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT).
Korenblat PE; Kemp JP; Scherger JE; Minkwitz MC; Mezzanotte W
Ann Allergy Asthma Immunol; 2000 Feb; 84(2):217-25. PubMed ID: 10719780
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of Zafirlukast ('Accolate') in the management of patients with mild-to-moderate asthma.
Chukwu C; Okpapi J; Ige MO; Obodo JO
West Afr J Med; 2000; 19(2):111-9. PubMed ID: 11070746
[TBL] [Abstract][Full Text] [Related]
4. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.
Fish JE; Kemp JP; Lockey RF; Glass M; Hanby LA; Bonuccelli CM
Clin Ther; 1997; 19(4):675-90. PubMed ID: 9377612
[TBL] [Abstract][Full Text] [Related]
5. An open study to evaluate the safety and efficacy of zafirlukast ("Accolate") in patients with mild to moderate asthma in Ibadan, Nigeria.
Ige OM; Onadeko BO
West Afr J Med; 2001; 20(4):220-6. PubMed ID: 11885876
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma.
Kemp JP; Minkwitz MC; Bonuccelli CM; Warren MS
Chest; 1999 Feb; 115(2):336-42. PubMed ID: 10027429
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses.
Tashkin DP; Nathan RA; Howland WC; Minkwitz MC; Simonson SG; Bonuccelli CM
J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):246-54. PubMed ID: 9949315
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of zafirlukast in the treatment of patients with bronchial asthma.
Tsai JJ; Chan SC; Ho CK; Su YC; Feng TC
J Microbiol Immunol Infect; 2001 Mar; 34(1):63-70. PubMed ID: 11321130
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial.
Grossman J; Smith LJ; Wilson AM; Thyrum PT
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):361-9. PubMed ID: 10227334
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
Suissa S; Dennis R; Ernst P; Sheehy O; Wood-Dauphinee S
Ann Intern Med; 1997 Feb; 126(3):177-83. PubMed ID: 9027267
[TBL] [Abstract][Full Text] [Related]
11. Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.
Dunn CJ; Goa KL
Drugs; 2001; 61(2):285-315. PubMed ID: 11270943
[TBL] [Abstract][Full Text] [Related]
12. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.
Adkins JC; Brogden RN
Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793
[TBL] [Abstract][Full Text] [Related]
13. [Leukotriene antagonists--do they have a value?].
Stey C
Praxis (Bern 1994); 2000 Mar; 89(14):586-90. PubMed ID: 10815466
[TBL] [Abstract][Full Text] [Related]
14. Zafirlukast improves pulmonary function in patients with moderate persistent asthma receiving regular inhaled steroids: a prospective randomized control study.
Huang CJ; Wang CH; Liu WT; Yang MC; Lin HC; Yu CT; Shiao CJ; Tan CC; Yang CK; Kuo HP
Chang Gung Med J; 2003 Aug; 26(8):554-60. PubMed ID: 14609035
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of asthmatic patients with zafirlukast].
Naranjo RM; Olivares Elegia M; de la Coba RA
Rev Alerg Mex; 2007; 54(1):3-6. PubMed ID: 17542248
[TBL] [Abstract][Full Text] [Related]
16. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials.
Barnes NC; Miller CJ
Thorax; 2000 Jun; 55(6):478-83. PubMed ID: 10817796
[TBL] [Abstract][Full Text] [Related]
17. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
Kelloway JS
Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243
[TBL] [Abstract][Full Text] [Related]
18. Summary of clinical trials with zafirlukast.
Calhoun WJ
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S238-45; discussion S245-8. PubMed ID: 9647606
[TBL] [Abstract][Full Text] [Related]
19. Asthma outcome changes associated with use of the leukotriene-receptor antagonist zafirlukast.
Klingman D; Bielory L; Wang Y; Silverman S; Bell CF; Joy KA; Dever MT; Jones DA
Manag Care Interface; 2001 Feb; 14(2):62-6. PubMed ID: 11228819
[TBL] [Abstract][Full Text] [Related]
20. Management of asthma with zafirlukast. Clinical experience and tolerability profile.
Spector SL
Drugs; 1996; 52 Suppl 6():36-46. PubMed ID: 8941502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
